In case of negative modulation of tumor growth, such as in ovarian cancer, non-small cell lung carcinoma, and cervical cancer, the increased presence of CD20+ B-cell TILs correlated with improved survival and subsequent lower relapse rates. Here, MS4A1 is linked to non-small cell lung carcinoma.